Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. (ticker: VVOS) is an NASDAQ-listed surgical & medical instruments & apparatus company. DredgeCap's structured extraction of VVOS's SEC filings surfaces 8 active risk signals, including 6 late-filing signals, and 2 auditor-change signals. VVOS reported $17.44M in revenue and -$21.17M for the period ending 2025-12-31, with operating cash flow of -$15.26M. Cash and equivalents stood at $2.03M (down 67.6% year-over-year). Total assets of $25.15M are exceeded by total liabilities of $26.70M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.